NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
Rhea-AI Summary
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder treatments, has scheduled its fiscal third quarter 2025 earnings release and conference call. The company will announce financial results for the quarter ended June 30, 2025, before market open on August 14, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern Time to discuss quarterly results and provide a corporate update. The call will include a Q&A session for telephone participants, with replay access available until August 28, 2025.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NMTC declined 4.85%, reflecting a moderate negative market reaction. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $43M at that time.
Data tracked by StockTitan Argus on the day of publication.
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, May 14, 2025, to discuss the Company’s third quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Third Quarter 2025 Earnings Conference Call
Date: Thursday, August 14, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 939482
Webcast: 3Q Webcast Link
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Thursday, August 28, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52598. A webcast replay will also be available using the webcast link above through August 28, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When will NeuroOne (NASDAQ: NMTC) report Q3 2025 earnings?
How can investors access NeuroOne's Q3 2025 earnings call?
Until when will NeuroOne's Q3 2025 earnings call replay be available?
What is NeuroOne's main business focus?
